Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Cosmina, Hogea"'
Publikováno v:
Oncology and Therapy, Vol 12, Iss 4, Pp 753-774 (2024)
Abstract Introduction Myelodysplastic syndromes (MDS) are characterized by bone marrow failure, peripheral blood cytopenias and a high risk of progression to acute myeloid leukemia (AML), which is associated with a poor prognosis and low survival rat
Externí odkaz:
https://doaj.org/article/08125e752128445ca86212cba371a798
Autor:
Rohan Shah, Anusorn Thanataveerat, Ricky Rudraraju, Kelly Curtis, Teraneh Z. Jhaveri, Gulce Askin, Debra Irwin, Jason Dinoso, Cosmina Hogea, Eduardo J. Sabate, Matthew Radford, Arman P. Sali, Mellissa Williamson
Publikováno v:
HemaSphere, Vol 7, p e531364a (2023)
Externí odkaz:
https://doaj.org/article/ef177e5abd4347ad9060b51ef3310f2c
Autor:
Michelle McNamara, Philip O. Buck, Songkai Yan, Leonard R. Friedland, Kristin Lerch, Alysa Murphy, Cosmina Hogea
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 9, Pp 2217-2226 (2019)
This study evaluated physician practices and perceived barriers for influenza, tetanus, diphtheria, pertussis (Tdap), and zoster vaccination of adults in the United States (US), with emphasis on patients with Medicare versus commercial insurance. A c
Externí odkaz:
https://doaj.org/article/0129690906644808a4f92b2abfaee96e
Autor:
Elizabeth M. La, Laurel Trantham, Samantha K. Kurosky, Dawn Odom, Emmanuel Aris, Cosmina Hogea
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 2, Pp 430-441 (2018)
Despite longstanding recommendations for routine vaccination against influenza; pneumococcal; tetanus, diphtheria, acellular pertussis (Tdap); and herpes zoster (HZ) among the United States general adult population, vaccine uptake remains low. Unders
Externí odkaz:
https://doaj.org/article/b562d1a8a8ad4e57ad99bc387f41bb04
Autor:
Katherine A. Hicks, Parinaz Ghaswalla, Justin Carrico, Seri Anderson, Patricia Novy, Cosmina Hogea, Mary S. Hayney
Publikováno v:
Journal of American College Health. :1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::597790a45038961b9b063180b000af95
https://doi.org/10.1080/07448481.2022.2163854
https://doi.org/10.1080/07448481.2022.2163854
Autor:
Andreas, Nikolaou, Cosmina, Hogea, Yevgeniy, Samyshkin, Eric M, Maiese, Leah, Sansbury, Mustafa, Oguz, Javier, Cid-Ruzafa, Ritika, Kapoor, Feng, Wang
Publikováno v:
Value in Health. 25:1977-1985
Estimates on the distribution of patients with multiple myeloma (MM) by line of therapy (LOT) are scarce and get outdated quickly as new treatments become available. The objective of this study was to estimate the number of patients with MM by LOT an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f9cfa14917be5e9f29ed02fb7576ec
https://doi.org/10.1016/j.jval.2022.05.011
https://doi.org/10.1016/j.jval.2022.05.011
Autor:
Guido España, Cosmina Hogea, Adrienne Guignard, Quirine A Ten Bosch, Amy C Morrison, David L Smith, Thomas W Scott, Alexander Schmidt, T Alex Perkins
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210041 (2019)
Vaccine efficacy (VE) estimates are crucial for assessing the suitability of dengue vaccine candidates for public health implementation, but efficacy trials are subject to a known bias to estimate VE toward the null if heterogeneous exposure is not a
Externí odkaz:
https://doaj.org/article/ef760ace62b2464b907feebbfd6660f0
Autor:
Cosmina Hogea, Ami R Buikema, Patricia Novy, Gary S. Marshall, Parinaz Ghaswalla, Lindsay G S Bengtson, Tim Bancroft, Eleena Koep
Publikováno v:
Clinical Infectious Diseases. 75:155-158
Meningococcal vaccination is recommended for patients with complement component deficiencies (CDs) in the United States. In this retrospective database study, only 4.6% and 2.2% of patients received MenACWY and MenB vaccination, respectively, within
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e25c01a3d55ef95628939564f347fe
https://doi.org/10.1093/cid/ciab917
https://doi.org/10.1093/cid/ciab917
Autor:
Ben Gutierrez, Yevgeniy Samyshkin, Venediktos Kapetanakis, Boris Gorsh, Andreas Nikolaou, Jon Tosh, Attaya Suvannasankha, Anshul Shah, Feng Wang, Wenkang Ma, Jenny Willson, Cosmina Hogea, Apoorva Ambavane, Sandhya Sapra
Publikováno v:
Expert Review of Hematology. 14:1137-1145
Background Patients with relapsed/refractory multiple myeloma (RRMM) require several lines of therapy, with typically shorter remission duration with each additional line. Research design and methods The cost-effectiveness of belantamab mafodotin (be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58aca6e288a8c82d118661d889f57167
https://doi.org/10.1080/17474086.2021.1970522
https://doi.org/10.1080/17474086.2021.1970522
Autor:
Boris Gorsh, Jenny Willson, Grammati Sarri, Rachel Hughes, Feng Wang, Shannon Ferrante, Thibaud Prawitz, Cosmina Hogea, Rakesh Popat, Attaya Suvannasankha, Venediktos Kapetanakis
Publikováno v:
Advances in Therapy
Introduction Single-agent belantamab mafodotin (belamaf; BLENREP) demonstrated deep and durable responses in patients with relapsed/refractory multiple myeloma and ≥ 3 prior lines of therapy, including an immunomodulatory agent, proteasome inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c95b144cdbc63217b7820fb76303c72
http://europepmc.org/articles/PMC8523001
http://europepmc.org/articles/PMC8523001